Cases 11 - 20 of 20
Pharmacyclics LLC et al v. Hetero USA Inc. et al
as 1:2019cv00014
Defendant:
Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Hetero USA Inc. et al
as 1:2018cv01778
Defendant:
Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sun Pharma Global FZE et al
as 1:2018cv01543
Defendant:
Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Acerta Pharma B.V. et al v. Pharmacyclics LLC et al
as 1:2018cv00581
Defendant:
AbbVie Inc. and Pharmacyclics LLC
Plaintiff:
AstraZeneca Pharmaceuticals LP, Acerta Pharma B.V. and AstraZeneca UK Ltd.
Intervenor Defendant:
Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Zydus Worldwide DMCC et al
as 1:2018cv00275
Defendant:
Teva Pharmaceuticals USA, Inc., Zydus Worldwide DMCC, Lek Pharmaceuticals d.d. and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Cipla Limited et al
as 1:2018cv00247
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Shilpa Medicare Limited et al
as 1:2018cv00237
Plaintiff:
Pharmacyclics LLC and Janssen Biotech Inc.
Defendant:
Shilpa Medicare Limited , Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sandoz Inc. et al
as 1:2018cv00192
Defendant:
Fresenius Kabi Oncology Limited, Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech Inc.
Counter Claimant:
Cipla USA Inc., Lek Pharmaceuticals d.d., Cadila Healthcare Limited and others
Cause Of Action: 35 U.S.C. § 271
MorphoSys AG v. Janssen Biotech Inc. et al
as 1:2016cv00221
Plaintiff:
MorphoSys AG
Defendant:
Janssen Biotech Inc. , Genmab A/S and Genmab US, Inc.
Cause Of Action: 35 U.S.C. § 271
Janssen Biotech Inc. et al v. Amneal Pharmaceuticals LLC et al
as 1:2015cv00679
Plaintiff:
Janssen Biotech Inc. , Janssen Oncology Inc. and Janssen Research & Development LLC
Defendant:
Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Par Pharmaceutical Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
